Mebendazole chewable tablets - Janssen

Drug Profile

Mebendazole chewable tablets - Janssen

Alternative Names: Vermox

Latest Information Update: 31 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Janssen
  • Class Anthelmintics; Benzimidazoles; Carbamates
  • Mechanism of Action Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Helminthiasis
  • New Molecular Entity No

Highest Development Phases

  • Registered Helminthiasis

Most Recent Events

  • 30 Oct 2017 Janssen's mebendazole chewable tablets (500mg) are available for Helminthiasis as part of global product donation programme and are not intended for commercial sale
  • 04 Aug 2017 Chemical structure information added
  • 13 Jun 2017 Registered for Helminthiasis in USA (PO, 100 mg)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top